UBS O'Connor’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-7,664,245
Closed -$887M 723
2023
Q3
$887M Buy
7,664,245
+3,332,978
+77% +$358M 15.86% 2
2023
Q2
$445M Buy
4,331,267
+338,535
+8% +$35.7M 9.42% 1
2023
Q1
$434M Buy
3,992,732
+1,706,942
+75% +$189M 10.37% 1
2022
Q4
$260M Buy
2,285,790
+2,211,443
+2,974% +$184M 17.09% 2
2022
Q3
$4.6M Sell
74,347
-5,000
-6% -$349K 0.05% 324
2022
Q2
$6.33M Buy
+79,347
New +$7.51M 0.07% 179
2016
Q2
Sell
-100,000
Closed -$1.66M 569
2016
Q1
$1.66M Buy
100,000
+62,987
+170% +$1.1M 0.03% 284
2015
Q4
$802K Sell
37,013
-47,387
-56% -$922K 0.01% 336
2015
Q3
$1.67M Buy
+84,400
New +$2.67M 0.03% 308
2013
Q3
Sell
-120,000
Closed -$295K 667
2013
Q2
$295K Buy
+120,000
New +$288K 0.01% 443

Other funds holding HZNP